First, in the retrospective case–control study reported here, we found that patients with CRC cancer have a much higher MIC-1 level in serum compared with healthy controls as reported before, implying that serum MIC-1 would serve as a potential serum biomarker for differential diagnosis of CRC. The gene discussed is GDF15; the disease is colorectal carcinoma.